Cited by 93Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The association between PGC-1α and Alzheimer's disease

Open access
Sweeney, Gary, Song, Juhyun·2016·Anatomy & Cell Biology

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder and its reported pathophysiological features in the brain include the deposition of amyloid beta peptide, chronic inflammation, and cognitive impairment. The incidence of AD is increasing worldwide and researchers have studied various aspects of AD pathophysiology in order to improve our understanding of the disease. Thus far, the onset mechanisms and means of preventing AD are completely unknown. Peroxisome proliferator-activated receptor-γ coactivator (PGC-1α) is a protein related to various cellular mechanisms that lead to the alteration of downstream gene regulation. It has been reported that PGC-1α could protect cells against oxidative stress and reduce mitochondrial dysfunction. Moreover, it has been demonstrated to have a regulatory role in inflammatory signaling and insulin sensitivity related to cognitive function. Here, we present further evidence of the involvement of PGC-1α in AD pathogenesis. Clarifying the relationship between PGC-1α and AD pathology might highlight PGC-1α as a possible target for therapeutic intervention in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5115/acb.2016.49.1.1

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PPARGC1A/PGC-1α regulates mitochondrial function and cellular responses to oxidative stress and has been implicated in AD-associated metabolic dysfunction.

    “PPARGC1A/PGC-1α regulates mitochondrial function and cellular responses to oxidative stress and has been implicated in AD-associated metabolic dysfunction (Sweeney and Song, 2016).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [2]Mattson MP Energy intake and exercise as determinants of brain health and vulnerability to injury and disease Cell Metab 2012 16 706 722 23168220 PMC3518570
  2. [3]De Felice FG Alzheimer's disease and insulin resistance: translating basic science into clinical applications J Clin Invest 2013 123 531 539 23485579 PMC3561831
  3. [4]Puigserver P Wu Z Park CW Graves R Wright M Spiegelman BM A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 1998 92 829 839 9529258
  4. [5]Scarpulla RC Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells Gene 2002 286 81 89 11943463
  5. [6]Qin W Haroutunian V Katsel P Cardozo CP Ho L Buxbaum JD Pasinetti GM PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia Arch Neurol 2009 66 352 361 19273754 PMC3052997
  6. [7]Zheng B Liao Z Locascio JJ Lesniak KA Roderick SS Watt ML Eklund AC Zhang-James Y Kim PD Hauser MA Grunblatt E Moran LB Mandel SA Riederer P Miller RM Federoff HJ Wüllner U Papapetropoulos S Youdim MB Cantuti-Castelvetri I Young AB Vance JM Davis RL Hedreen JC Adler CH Beach TG Graeber MB Middleton FA Rochet JC Scherzer CR Global PD Gene Expression (GPEX) Consortium PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease Sci Transl Med 2010 2 52ra73 PMC3129986 20926834
  7. [9]Luca M Luca A Calandra C The role of oxidative damage in the pathogenesis and progression of Alzheimer's disease and vascular dementia Oxid Med Cell Longev 2015 2015 504678 26301043 PMC4537746
  8. [11]Mendoza E Miranda-Barrientos JA Vázquez-Roque RA Morales-Herrera E Ruelas A De la Flores G Hernández-Echeagaray E In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins Neuroscience 2014 280 156 170 25241069
  9. [13]Kimata T Sasakura H Ohnishi N Nishio N Mori I Thermotaxis of C. elegans as a model for temperature perception, neural information processing and neural plasticity Worm 2012 1 31 41 24058821 PMC3670169
  10. [14]Stein GM Murphy CT The intersection of aging, longevity pathways, and learning and memory in C. elegans Front Genet 2012 3 259 23226155 PMC3509946
  11. [15]Willette AA Bendlin BB Starks EJ Birdsill AC Johnson SC Christian BT Okonkwo OC La Rue A Hermann BP Koscik RL Jonaitis EM Sager MA Asthana S Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease JAMA Neurol 2015 72 1013 1020 26214150 PMC4570876
  12. [16]Cai Z Xiao M Chang L Yan LJ Role of insulin resistance in Alzheimer's disease Metab Brain Dis 2015 30 839 851 25399337
  13. [17]St-Pierre J Drori S Uldry M Silvaggi JM Rhee J Jäger S Handschin C Zheng K Lin J Yang W Simon DK Bachoo R Spiegelman BM Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 2006 127 397 408 17055439
  14. [18]Baur JA Pearson KJ Price NL Jamieson HA Lerin C Kalra A Prabhu VV Allard JS Lopez-Lluch G Lewis K Pistell PJ Poosala S Becker KG Boss O Gwinn D Wang M Ramaswamy S Fishbein KW Spencer RG Lakatta EG Le Couteur D Shaw RJ Navas P Puigserver P Ingram DK de Cabo R Sinclair DA Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006 444 337 342 17086191 PMC4990206
  15. [23]Lai L Wang M Martin OJ Leone TC Vega RB Han X Kelly DP A role for peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis J Biol Chem 2014 289 2250 2259 24337569 PMC3900969
  16. [24]Pinho RA Pinho CA Tromm CB Pozzi BG Souza DR Silva LA Tuon T Souza CT Changes in the cardiac oxidative metabolism induced by PGC-1{alpha}: response of different physical training protocols in infarction-induced rats Int J Cardiol 2013 168 4560 4562 23880578
  17. [25]Weydt P Pineda VV Torrence AE Libby RT Satterfield TF Lazarowski ER Gilbert ML Morton GJ Bammler TK Strand AD Cui L Beyer RP Easley CN Smith AC Krainc D Luquet S Sweet IR Schwartz MW La Spada AR Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration Cell Metab 2006 4 349 362 17055784
  18. [26]Lin J Wu PH Tarr PT Lindenberg KS St-Pierre J Zhang CY Mootha VK Jäger S Vianna CR Reznick RM Cui L Manieri M Donovan MX Wu Z Cooper MP Fan MC Rohas LM Zavacki AM Cinti S Shulman GI Lowell BB Krainc D Spiegelman BM Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice Cell 2004 119 121 135 15454086
  19. [27]Herzig S Long F Jhala US Hedrick S Quinn R Bauer A Rudolph D Schutz G Yoon C Puigserver P Spiegelman B Montminy M CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature 2001 413 179 183 11557984
  20. [28]Nisoli E Clementi E Paolucci C Cozzi V Tonello C Sciorati C Bracale R Valerio A Francolini M Moncada S Carruba MO Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 2003 299 896 899 12574632
  21. [30]Procaccio V Bris C Chao de la Barca JM Oca F Chevrollier A Amati-Bonneau P Bonneau D Reynier P Perspectives of drug-based neuroprotection targeting mitochondria Rev Neurol (Paris) 2014 170 390 400 24792485
  22. [32]Krstic D Knuesel I Deciphering the mechanism underlying late-onset Alzheimer disease Nat Rev Neurol 2013 9 25 34 23183882
  23. [33]Nunomura A Moreira PI Castellani RJ Lee HG Zhu X Smith MA Perry G Oxidative damage to RNA in aging and neurodegenerative disorders Neurotox Res 2012 22 231 248 22669748
  24. [34]Sultana R Butterfield DA Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies J Alzheimers Dis 2013 33 Suppl 1 S243 S251 22683528
  25. [35]Bradley-Whitman MA Lovell MA Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update Arch Toxicol 2015 89 1035 1044 25895140 PMC4466146
  26. [36]Nunomura A Tamaoki T Motohashi N Nakamura M McKeel DW Jr Tabaton M Lee HG Smith MA Perry G Zhu X The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons J Neuropathol Exp Neurol 2012 71 233 241 22318126 PMC3288284
  27. [37]Jahani-Asl A Cheung EC Neuspiel M MacLaurin JG Fortin A Park DS McBride HM Slack RS Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death J Biol Chem 2007 282 23788 23798 17537722
  28. [38]Wu Z Puigserver P Andersson U Zhang C Adelmant G Mootha V Troy A Cinti S Lowell B Scarpulla RC Spiegelman BM Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 1999 98 115 124 10412986
  29. [39]Brand MD Uncoupling to survive? The role of mitochondrial inefficiency in ageing Exp Gerontol 2000 35 811 820 11053672
  30. [40]Rodgers JT Lerin C Gerhart-Hines Z Puigserver P Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways FEBS Lett 2008 582 46 53 18036349 PMC2275806
  31. [41]Ozden O Park SH Kim HS Jiang H Coleman MC Spitz DR Gius D Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress Aging (Albany NY) 2011 3 102 107 21386137 PMC3082006
  32. [42]Tsunemi T Ashe TD Morrison BE Soriano KR Au J Roque RA Lazarowski ER Damian VA Masliah E La Spada AR PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function Sci Transl Med 2012 4 142ra97 PMC4096245 22786682
  33. [43]Obulesu M Lakshmi MJ Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues Neurochem Res 2014 39 2301 2312 25322820
  34. [44]Bonda DJ Lee HP Lee HG Friedlich AL Perry G Zhu X Smith MA Novel therapeutics for Alzheimer's disease: an update Curr Opin Drug Discov Devel 2010 13 235 246 PMC2931269 20205057
  35. [45]Maruszak A Żekanowski C Mitochondrial dysfunction and Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry 2011 35 320 330 20624441
  36. [46]Picone P Nuzzo D Caruana L Scafidi V Di Carlo M Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Oxid Med Cell Longev 2014 2014 780179 25221640 PMC4158152
  37. [47]Atamna H Kumar R Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase J Alzheimers Dis 2010 20 S439 S452 20463399
  38. [48]Zubenko GS Sauer P SOD-1 activity and platelet membrane fluidity in Alzheimer's disease Biol Psychiatry 1989 25 671 678 2923930
  39. [49]Moreira PI Santos MS Sena C Nunes E Seiça R Oliveira CR CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats Exp Neurol 2005 196 112 119 16126199
  40. [50]Bishop NA Lu T Yankner BA Neural mechanisms of ageing and cognitive decline Nature 2010 464 529 535 20336135 PMC2927852
  41. [51]Aksenov V Long J Liu J Szechtman H Khanna P Matravadia S Rollo CD A complex dietary supplement augments spatial learning, brain mass, and mitochondrial electron transport chain activity in aging mice Age (Dordr) 2013 35 23 33 22120182 PMC3543739
  42. [52]Choksi KB Nuss JE DeFord JH Papaconstantinou J Mitochondrial electron transport chain functions in long-lived Ames dwarf mice Aging (Albany NY) 2011 3 754 767 21934186 PMC3184977
  43. [53]Hirayama M Nakamura T Watanabe H Uchida K Hama T Hara T Niimi Y Ito M Ohno K Sobue G Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease Parkinsonism Relat Disord 2011 17 46 49 21106430
  44. [54]Shacka JJ Roth KA Zhang J The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy Front Biosci 2008 13 718 736 17981582
  45. [55]Handschin C Kobayashi YM Chin S Seale P Campbell KP Spiegelman BM PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy Genes Dev 2007 21 770 783 17403779 PMC1838529
  46. [56]Cui L Jeong H Borovecki F Parkhurst CN Tanese N Krainc D Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 2006 127 59 69 17018277
  47. [57]Wareski P Vaarmann A Choubey V Safiulina D Liiv J Kuum M Kaasik A PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons J Biol Chem 2009 284 21379 21385 19542216 PMC2755862
  48. [58]Mootha VK Handschin C Arlow D Xie X St Pierre J Sihag S Yang W Altshuler D Puigserver P Patterson N Willy PJ Schulman IG Heyman RA Lander ES Spiegelman BM Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle Proc Natl Acad Sci U S A 2004 101 6570 6575 15100410 PMC404086
  49. [59]Ma D Li S Lucas EK Cowell RM Lin JD Neuronal inactivation of peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) protects mice from diet-induced obesity and leads to degenerative lesions J Biol Chem 2010 285 39087 39095 20947495 PMC2998117
  50. [60]Pandey G Makhija E George N Chakravarti B Godbole MM Ecelbarger CM Tiwari S Insulin regulates nitric oxide production in the kidney collecting duct cells J Biol Chem 2015 290 5582 5591 25533472 PMC4342472
  51. [61]Yu LY Pei Y Insulin neuroprotection and the mechanism Chin Med J (Engl) 2015 128 976 981 25836621 PMC4834017
  52. [62]Banks WA The source of cerebral insulin Eur J Pharmacol 2004 490 5 12 15094069
  53. [63]Kern W Born J Schreiber H Fehm HL Central nervous system effects of intranasally administered insulin during euglycemia in men Diabetes 1999 48 557 563 10078556
  54. [64]Schäfer M Erdö SL Development of glutamate neurotoxicity in cortical cultures: induction of vulnerability by insulin Brain Res Dev Brain Res 1991 62 293 296 1685107
  55. [65]Baker LD Cross DJ Minoshima S Belongia D Watson GS Craft S Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes Arch Neurol 2011 68 51 57 20837822 PMC3023149
  56. [67]Lourenco MV Clarke JR Frozza RL Bomfim TR Forny-Germano L Batista AF Sathler LB Brito-Moreira J Amaral OB Silva CA Freitas-Correa L Espirito-Santo S Campello-Costa P Houzel JC Klein WL Holscher C Carvalheira JB Silva AM Velloso LA Munoz DP Ferreira ST De Felice FG TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's beta-amyloid oligomers in mice and monkeys Cell Metab 2013 18 831 843 24315369
  57. [68]Talbot K Wang HY Kazi H Han LY Bakshi KP Stucky A Fuino RL Kawaguchi KR Samoyedny AJ Wilson RS Arvanitakis Z Schneider JA Wolf BA Bennett DA Trojanowski JQ Arnold SE Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 2012 122 1316 1338 22476197 PMC3314463
  58. [69]Duncan JG Fong JL Medeiros DM Finck BN Kelly DP Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway Circulation 2007 115 909 917 17261654 PMC4322937
  59. [70]Biddinger SB Hernandez-Ono A Rask-Madsen C Haas JT Alemán JO Suzuki R Scapa EF Agarwal C Carey MC Stephanopoulos G Cohen DE King GL Ginsberg HN Kahn CR Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis Cell Metab 2008 7 125 134 18249172 PMC4251554
  60. [71]Mitra R Nogee DP Zechner JF Yea K Gierasch CM Kovacs A Medeiros DM Kelly DP Duncan JG The transcriptional coactivators, PGC-1alpha and beta, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance J Mol Cell Cardiol 2012 52 701 710 22080103 PMC3294189
  61. [72]Ha CD Cho JK Han T Lee SH Kang HS Relationship of PGC-1alpha gene polymorphism with insulin resistance syndrome in Korean children Asia Pac J Public Health 2015 27 NP544 NP551 23449621

Cited by

Sorted by citations

Authors
Sweeney, G., & Song, J.
Affiliations
  • York University (CA)
  • Yonsei University (KR)
Corresponding author
Song, Juhyun
Venue
Anatomy & Cell Biology
Published
2016
Volume
49
Issue
1
Pages
1
ISSN
  • 2093-3665 (ISSN-L)
  • 2093-3673
OpenAlex
W2330994131
Cited by
93
References
11
Citations by year
2026: 5 · 2025: 7 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 12 · 2020: 22 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 2
FWCI
0.98
Type
journal article
Language
en
Update notices
erratum (2016-06-24)
Open access
Locations
  • Anatomy & Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
PGC-1α, Alzheimer's disease, amyloid-beta, neuroinflammation, oxidative stress, mitochondrial dysfunction, insulin sensitivity, cognitive impairment, gene expression regulation, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review